Cargando…

Large-scale mapping of the Ebola NP and GP proteins reveals multiple immunoprevalent and conserved CD4 T-cell epitopes

Detalles Bibliográficos
Autores principales:	Gallais, Yann, Sierocki, Raphaël, Lhomme, Gautier, Sivelle, Coline, Kiseljak, Divor, Wurm, Florian, Djoulah, Sami, Bouzidi, Ahmed, Kerzerho, Jérôme, Maillère, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7214855/ https://www.ncbi.nlm.nih.gov/pubmed/32398806 http://dx.doi.org/10.1038/s41423-020-0455-2

Ejemplares similares

Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity
por: Agnolon, Valentina, et al.
Publicado: (2020)

Immune Control of Burkholderia pseudomallei––Common, High-Frequency T-Cell Responses to a Broad Repertoire of Immunoprevalent Epitopes
por: Nithichanon, Arnone, et al.
Publicado: (2018)

Combining deep mutational scanning to heatmap of HLA class II binding of immunogenic sequences to preserve functionality and mitigate predicted immunogenicity
por: Sivelle, Coline, et al.
Publicado: (2023)

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
por: Tarke, Alison, et al.
Publicado: (2021)

Influence of glutamine on transient and stable recombinant protein production in CHO and HEK-293 cells
por: Rajendra, Yashas, et al.
Publicado: (2011)

Landscape of epitopes targeted by T cells in 852 individuals recovered from COVID-19: Meta-analysis, immunoprevalence, and web platform
por: Quadeer, Ahmed Abdul, et al.
Publicado: (2021)

Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology
por: Johnson, Reed F, et al.
Publicado: (2006)

The use of filler DNA for improved transfection and reduced DNA needs in transient gene expression with CHO and HEK cells
por: Kiseljak, Divor, et al.
Publicado: (2011)

Polyethyleneimine-based transient gene expression processes for suspension-adapted HEK-293E and CHO-DG44 cells
por: Hacker, David L., et al.
Publicado: (2013)

High Therapeutic Efficacy of a New Survivin LSP-Cancer Vaccine Containing CD4(+) and CD8(+) T-Cell Epitopes
por: Onodi, Fanny, et al.
Publicado: (2018)

Immunoproteomic analysis of a Chikungunya poxvirus-based vaccine reveals high HLA class II immunoprevalence
por: Lorente, Elena, et al.
Publicado: (2019)

In silico prediction of Ebola Zaire GP(1,2) immuno-dominant epitopes for the Balb/c mouse
por: Dutta, Debargh K., et al.
Publicado: (2015)

Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin †
por: Tumpara, Srinu, et al.
Publicado: (2021)

Professor G.P. Puppi, Leader of NP Division
por: CERN PhotoLab
Publicado: (1962)

An antigenic epitope of influenza virus nucleoprotein (NP) associated with polymeric forms of NP
por: Prokudina, Elena N, et al.
Publicado: (2008)

Structures of Ebola Virus GP and sGP in Complex with Therapeutic Antibodies
por: Pallesen, Jesper, et al.
Publicado: (2016)

GM-CSF Production Allows the Identification of Immunoprevalent Antigens Recognized by Human CD4+ T Cells Following Smallpox Vaccination
por: Judkowski, Valeria, et al.
Publicado: (2011)

Deep mutational engineering of broadly-neutralizing nanobodies accommodating SARS-CoV-1 and 2 antigenic drift
por: Laroche, Adrien, et al.
Publicado: (2022)

Immunoprevalence to Six Waterborne Pathogens in Beachgoers at Boquerón Beach, Puerto Rico: Application of a Microsphere-Based Salivary Antibody Multiplex Immunoassay
por: Augustine, Swinburne A. J., et al.
Publicado: (2017)

The Ebola Virus VP30-NP Interaction Is a Regulator of Viral RNA Synthesis
por: Kirchdoerfer, Robert N., et al.
Publicado: (2016)

Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging
por: Banadyga, Logan, et al.
Publicado: (2017)

Ebola Virus NP Binding to Host Protein Phosphatase-1 Regulates Capsid Formation
por: Ahmad, Asrar, et al.
Publicado: (2023)

An antibody targeting type III secretion system induces broad protection against Salmonella and Shigella infections
por: Sierocki, Raphaël, et al.
Publicado: (2021)

Ebola GP-Specific Monoclonal Antibodies Protect Mice and Guinea Pigs from Lethal Ebola Virus Infection
por: Qiu, Xiangguo, et al.
Publicado: (2012)

The role of the charged residues of the GP2 helical regions in Ebola entry
por: Jiang, Haiqing, et al.
Publicado: (2009)

Ebola sGP—The first viral glycoprotein shown to be C-mannosylated
por: Falzarano, Darryl, et al.
Publicado: (2007)

Comprehensive Functional Analysis of N-Linked Glycans on Ebola Virus GP1
por: Lennemann, Nicholas J., et al.
Publicado: (2014)

Shed GP of Ebola Virus Triggers Immune Activation and Increased Vascular Permeability
por: Escudero-Pérez, Beatriz, et al.
Publicado: (2014)

The Cellular Protein CAD is Recruited into Ebola Virus Inclusion Bodies by the Nucleoprotein NP to Facilitate Genome Replication and Transcription
por: Brandt, Janine, et al.
Publicado: (2020)

Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo
por: Bratcher, Anna, et al.
Publicado: (2021)

Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry
por: Singleton, Courtney D., et al.
Publicado: (2019)

Ebola Virus GP Activates Endothelial Cells via Host Cytoskeletal Signaling Factors
por: Moni, Benedicte Mpia, et al.
Publicado: (2022)

Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoproteins
por: Wu, Shipo, et al.
Publicado: (2012)

Correction: Zoonotic risk factors associated with seroprevalence of Ebola virus GP antibodies in the absence of diagnosed Ebola virus disease in the Democratic Republic of Congo
por: Bratcher, Anna, et al.
Publicado: (2022)

T cell epitope mapping of secukinumab and ixekizumab in healthy donors
por: Spindeldreher, Sebastian, et al.
Publicado: (2020)

Flexible docking-based molecular dynamics simulation of natural product compounds and Ebola virus Nucleocapsid (EBOV NP): a computational approach to discover new drug for combating Ebola
por: Nasution, Mochammad Arfin Fardiansyah, et al.
Publicado: (2018)

Super Potent Bispecific Llama VHH Antibodies Neutralize HIV via a Combination of gp41 and gp120 Epitopes
por: Strokappe, Nika M., et al.
Publicado: (2019)

Epitope mapping of Ebola virus dominant and subdominant glycoprotein epitopes facilitates construction of an epitope-based DNA vaccine able to focus the antibody response in mice
por: Mitchell, Daniel A. J., et al.
Publicado: (2017)

Structural definition of a conserved neutralization epitope on HIV-1 gp120
por: Zhou, Tongqing, et al.
Publicado: (2007)

Enhancing Exposure of HIV-1 Neutralization Epitopes through Mutations in gp41
por: Blish, Catherine A, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_me2qi5uq1u26gjapdpaoj6idvb